Clinically, DKK1- and CKAP4-positive patients with pancreatic ductal adenocarcinoma have shorter 5-years survival and relapse-free survival than DKK1- or CKAP4-negative patients. Here, CKAP4 is linked to pancreatic ductal adenocarcinoma.